Pfizer's Brincat to lead mobile Health at Exco InTouch
This article was originally published in Scrip
Exco InTouch, a provider of mobile patient communication solutions for the pharmaceutical and healthcare sectors, has appointed Mark Brincat product development director. Mr Brincat will lead the strategy and development of the firm's range of patient-centric and mobile Health (mHealth) solutions. He joins Exco InTouch from Pfizer, where he spent the last 13 years managing the delivery of emerging and innovative business technology.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.